Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DROXIDOPA vs DUPILUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DROXIDOPA vs DUPILUMAB: Safety Overview

Metric DROXIDOPA DUPILUMAB
Total FAERS Reports 20,119 379,249
Deaths Reported 2,500 1,536
Death Rate 12.4% 0.4%
Hospitalizations 2,900 17,008
Average Patient Age 67.7 yrs 44.7 yrs
% Female Patients 46.7% 61.2%
FDA Approval Date Apr 28, 2021 N/A
Manufacturer Aurobindo Pharma Limited sanofi-aventis U.S. LLC
Route ORAL SUBCUTANEOUS
Marketing Status Prescription Prescription